Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Y-27632 dihydrochloride for Organoid Workflows
2026-08-12
Y-27632 dihydrochloride is a selective ROCK inhibitor that can improve post-dissociation cell recovery while providing a controllable way to study cytoskeletal remodeling. This guide connects practical ROCK inhibition workflows with the Paneth-cell and intestinal stem-cell findings reported in a recent Nature Communications study.
-
WM-8014: A Practical KAT6A Inhibitor Workflow
2026-08-12
WM-8014 combines nanomolar biochemical potency with reversible, acetyl-CoA-competitive inhibition to support cleaner studies of KAT6A/B biology. This guide translates its use into cell-cycle, senescence, CRISPR-screen validation, and tumor-growth workflows while addressing solubility and exposure-design limitations.
-
mPTP–mtDNA Signaling in Ferroptosis
2026-08-11
A 2026 Advanced Science study identifies CypD-dependent mitochondrial permeability transition pore opening as a key route for oxidized mitochondrial DNA release during ferroptosis. The work connects mitochondrial swelling to cGAS–STING activation, ferritinophagy, and tumor suppression, providing a mechanistic framework for interpreting mitochondria-dependent ferroptotic signaling.
-
Myriocin Workflows for SPT and Mitochondrial Assays
2026-08-11
Myriocin gives researchers a direct way to perturb de novo sphingolipid synthesis while measuring proliferation, cell-cycle signaling, and mitochondrial performance. This workflow-oriented guide connects selective SPT inhibition with lipidomics, cancer models, immune studies, and the mitochondrial assays highlighted in recent yeast longevity research.
-
Ginkgo Compound Cocktail Improves Yeast Longevity
2026-08-10
This study combines LC–MS/MS profiling, network pharmacology, and yeast aging assays to identify a four-compound Ginkgo biloba cocktail that improves mitochondrial function and extends chronological lifespan. Its main innovation is the experimental reduction of a complex botanical extract into a synergistic combination of quercetin, rutin, ginkgolide B, and isorhamnetin, while linking the phenotype to oxidative stress and mitochondrial endpoints.
-
mTORC1 Oscillations Control Mitosis and Autophagy
2026-08-09
Joshi and colleagues show that mTORC1 activity is dynamically regulated across the cell cycle, reaching its highest level in S/G2 and its lowest level in mitosis and G1. The study links these oscillations to S-phase and G2 progression, Chk1/Wee1-dependent mitotic entry, and phase-specific sensitivity to autophagy induction.
-
Myriocin as a Causal Probe of Sphingolipid Biology
2026-08-08
Myriocin is a potent serine palmitoyltransferase inhibitor that can turn broad mitochondrial and longevity phenotypes into testable sphingolipid hypotheses. This article connects a Ginkgo biloba yeast study with rigorous assay design, mechanistic controls, and translational limitations.
-
Nanoparticle Uptake by Human Corneal Epithelial Cells
2026-08-07
This 2024 study shows that nanoparticle size and surface chemistry shape how PLGA nanoparticles interact with human corneal epithelial cells. Its in vitro model identifies energy-dependent uptake, with macropinocytosis and caveolae-mediated endocytosis as dominant pathways, providing design guidance for topical ocular delivery systems.
-
Quercetin as a PI3K Inhibitor: Optimized Workflows for Cance
2026-08-07
Quercetin stands out as a robust PI3K inhibitor and apoptosis inducer in experimental cancer and neuroinflammation models. This article demystifies stepwise protocols, troubleshooting, and cross-domain applications, drawing on the latest reference study and real-world lab scenarios.
-
Imatinib (STI571): Streamlining Tumor Microenvironment Assay
2026-08-06
Imatinib (STI571) empowers researchers to dissect tyrosine kinase signaling in complex tumor models, enabling high-fidelity signal transduction and cancer biology research. Discover protocol enhancements, troubleshooting strategies, and the impact of stromal components on kinase inhibitor response.
-
Oscillatory mTORC1 Dynamics Govern Mitotic Entry and Autopha
2026-08-06
Joshi et al. reveal that mTORC1 activity oscillates across the cell cycle, peaking in S/G2 and reaching its lowest in mitosis and G1. This dynamic regulation shapes mitotic entry and modulates sensitivity to autophagy, providing new mechanistic insights into cell cycle control and metabolic adaptation in proliferating cells.
-
Myriocin: Potent Serine Palmitoyltransferase Inhibitor for S
2026-08-05
Myriocin is a highly selective inhibitor of serine palmitoyltransferase (SPT) employed in sphingolipid metabolism research. It effectively blocks de novo sphingolipid biosynthesis, yielding robust immunosuppressive and antiproliferative effects in oncology and immunology models. This article details its molecular mechanism, validated benchmarks, and practical workflow integration.
-
Deferasirox Fe3+ Chelate: Advanced Workflows in Iron Overloa
2026-08-05
Deferasirox Fe3+ chelate enables precise modeling of iron overload and myeloid differentiation, thanks to its robust Fe3+ binding and exceptional DMSO solubility. This article unpacks optimized lab protocols, troubleshooting guidance, and the latest mechanistic insights for researchers studying iron metabolism and hematopoietic modulation.
-
GATA6 Loss Drives Lineage Plasticity and Metastasis in CRC
2026-08-04
This study reveals that loss of the transcription factor GATA6 triggers multilineage plasticity and enhances liver metastasis in colorectal cancer (CRC), independent of primary tumor growth. By employing a pro-metastatic CRC organoid library and integrative genomic analyses, the research identifies GATA6 as a central epigenetic regulator of metastatic progression, with implications for targeting lineage plasticity in advanced CRC.
-
Tris(2-carboxyethyl) Phosphine Hydrochloride: Workflow and I
2026-08-04
Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) is transforming protein analysis, redox workflows, and advanced biochemical assays by offering stable, odorless, and selective disulfide reduction. Here, we dissect how TCEP hydrochloride, supplied by APExBIO, underpins next-generation experimental protocols and troubleshooting for researchers seeking reliable results.